Drugs / Tongjiang granules
Tongjiang granules
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT04340297 | Jun 2020 → Dec 2021 | gastroesophageal reflux disease | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT04454996 | Jun 2020 → Sep 2021 | irritable bowel syndrome | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tong-jiang granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04454996 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “This is a kind of compound Chinese medicine granules” NCT04454996 ↗ |
| Route | Oral | “Tongjiang granules are taken orally” NCT04340297 ↗ |